---

A randomized trial to compare the maternal and fetal outcomes and adverse effects of both intravenous labetalol and oral nifedipine

---

Original Article

Author Details : Pratibha Kumari*, Onam Kumari, Sangeeta Pankaj, Kumudini Jha

Volume : 9, Issue : 1, Year : 2022

Article Page : 59-65

https://doi.org/10.18231/j.ijogr.2022.012

Suggest article by email

Get Permission

---

Abstract

Hypertensive disorders of pregnancy is one of the most common causes of high maternal mortality in India and globally as well. Hypertension in pregnancy is associated with many adverse effects for both mother and baby. Blood pressure reading ?160/110 mmHg is often associated with increased risk of complications like placental abruption, pulmonary edema, hypertensive encephalopathy, intracranial hemorrhage, eclampsia and other end organ damage with poor perinatal outcome. The present study aimed to compare the two most commonly used drugs, oral nifedipine and IV labetalol in terms of their adverse effects, maternal and perinatal outcomes. Both intravenous labetalol and nifedipine have been compared directly with many other antihypertensive agents; however, literature on their direct comparison with each other for adverse effect is very limited.
 

Keywords: Hypertension, Pregnancy, Pre-eclampsia, Labetalol and nifedipine.

How to cite : Kumari P, Kumari O, Pankaj S, Jha K, A randomized trial to compare the maternal and fetal outcomes and adverse effects of both intravenous labetalol and oral nifedipine. Indian J Obstet Gynecol Res 2022;9(1):59-65

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.